Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 |Industry: Pharmaceuticals
|Mid-range Performer
523.00 -2.75 (-0.52%)
NSE Jun 17, 2019 15:31
Volume: 528.5K
 
Durability score
65 /100
High Financial Strength
Valuation score
36.2 /100
Mid Valuation
Momentum score
38.4 /100
Neutral Momentum
Market Capitalizati...
14,757.5 Cr.
High in industry
AVG Broker Target
616.9
17.95% upside
PE TTM Price to Ear...
16.0
Above industry median.
Fetching latest news from server
Poll
VOTE: What's your call on Glenmark Pharmaceuticals Limited?
Total Votes: 99
BUY
SELL
HOLD
82.83%
12.12%
5.05%
  • HDFC Securities decreased Buy price target of Glenmark Pharmaceuticals Ltd. to 730.0 on 31 May, 2019.
  • Stock Price (597.2) crossed below 200 Day SMA (631.52) on 08 May, 2019
  • Stock Price (634.9) crossed above 50 Day SMA (628.15) on 07 May, 2019
  • Stock Price (622.15) crossed below 150 Day SMA (636.85) on 02 May, 2019
  • Stock Price (634.0) crossed below 30 Day SMA (643.09) on 30 April, 2019
More triggered alerts
Ex-Date Dividend Amount Dividend Type Record Date
Sept. 19, 20182.00FINAL-
Sept. 20, 20172.00FINAL-
Aug. 3, 20162.00FINAL-
Sept. 10, 20152.00FINAL-
July 10, 20142.00FINAL-
All dividends by GLENMARK
Ex-Date Dividend Bonus Ratio Record Date
March 4, 20051:1-
All bonuses by GLENMARK
Ex-Date Dividend Old FVNew FV Record Date
Sept. 10, 200721-
Oct. 23, 2003102Oct. 31, 2003
All splits by GLENMARK